Large Biotech Streamlines Investigator’s Brochures with Certara’s Project Management Expertise Case Study Large Biotech Streamlines Investigator’s Brochures with Certara’s Project Management Expertise Learn how Certara's project management team helped a large biotech streamline the development and updates…CertaraSeptember 5, 2025
The Pharmacometrics Africa Conference 2025 (PMXAC-2025) Conference The Pharmacometrics Africa Conference 2025 (PMXAC-2025) CertaraSeptember 4, 2025
The Many Challenges of Patient Narrative Writing | RAPS Sponsored Webinar On-Demand Webinar The Many Challenges of Patient Narrative Writing | RAPS Sponsored Webinar Watch Certara’s RAPS-sponsored on-demand webinar to learn how automation and expert strategies simplify patient narrative…CertaraAugust 18, 2025
Small Biotech Clinical Trial Application (CTA) & Investigational New Drug (IND) Submission Success with Integrated Project Management Case Study Small Biotech Clinical Trial Application (CTA) & Investigational New Drug (IND) Submission Success with Integrated Project Management Find out how Certara helped a small biotech achieve on-time IND and CTA submissions with…CertaraAugust 18, 2025
Population Pharmacokinetics for Belantamab Mafodotin Monotherapy and Combination Therapies in Patients with Relapsed/Refractory Multiple Myeloma Publication Population Pharmacokinetics for Belantamab Mafodotin Monotherapy and Combination Therapies in Patients with Relapsed/Refractory Multiple Myeloma Explore comprehensive population pharmacokinetic analyses of belantamab mafodotin, evaluating both monotherapy and combination regimens in…CertaraAugust 13, 2025
Sacituzumab Govitecan Population Pharmacokinetics: Updated Analyses Using HR+/HER2− Metastatic Breast Cancer Data From the Phase 3 TROPiCS‐02 Trial Publication Sacituzumab Govitecan Population Pharmacokinetics: Updated Analyses Using HR+/HER2− Metastatic Breast Cancer Data From the Phase 3 TROPiCS‐02 Trial Explore updated results from the Phase 3 TROPiCS-02 trial of Sacituzumab Govitecan in advanced HR+/HER2–…CertaraAugust 13, 2025
Replacing traditional TQT studies with model-based concentration-qtc (C-qtc) analysis for cardiovascular safety in drug development Blog Replacing traditional TQT studies with model-based concentration-qtc (C-qtc) analysis for cardiovascular safety in drug development Learn how our experts use concentration-QTc (C-QTc) analysis to replace costly TQT studies, streamline QT…CertaraAugust 6, 2025
De-risking DDI Management during Clinical Trials: Introducing DIDB’s Concomitant Meds Navigator On-Demand Webinar De-risking DDI Management during Clinical Trials: Introducing DIDB’s Concomitant Meds Navigator Watch the on-demand presentation covering how the DIDB® Concomitant Meds Navigator empowers clinical development teams…CertaraAugust 5, 2025
ADNCA explained: The next generation of non-compartmental analysis and the top questions answered Blog ADNCA explained: The next generation of non-compartmental analysis and the top questions answered ADNCA is transforming non-compartmental analysis by standardizing workflows, enhancing regulatory confidence, and enabling scalable automation.…CertaraJuly 23, 2025